Because low serum irisin was found to be associated with type 2 diabetes and obesity [15-17] and both these two conditions were independent risk factors of CKD [1], it is suspected that CKD patients have altered irisin levels. This evidence concerns the gene FNDC5 and obesity due to melanocortin 4 receptor deficiency.